- Home
- M vs PRCT Comparison
M vs PRCT Comparison
Compare M & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- M
- PRCT
- Stock Information
- Founded
- M 1830
- PRCT 2009
- Country
- M United States
- PRCT United States
- Employees
- M N/A
- PRCT N/A
- Industry
- M Department/Specialty Retail Stores
- PRCT Medical Specialities
- Sector
- M Consumer Discretionary
- PRCT Health Care
- Exchange
- M Nasdaq
- PRCT Nasdaq
- Market Cap
- M 3.3B
- PRCT 3.2B
- IPO Year
- M N/A
- PRCT 2021
- Fundamental
- Price
- M $11.05
- PRCT $60.22
- Analyst Decision
- M Hold
- PRCT Strong Buy
- Analyst Count
- M 10
- PRCT 7
- Target Price
- M $13.22
- PRCT $90.00
- AVG Volume (30 Days)
- M 7.8M
- PRCT 819.9K
- Earning Date
- M 05-28-2025
- PRCT 07-31-2025
- Dividend Yield
- M 6.61%
- PRCT N/A
- EPS Growth
- M N/A
- PRCT N/A
- EPS
- M 1.98
- PRCT N/A
- Revenue
- M $22,799,000,000.00
- PRCT $249,121,000.00
- Revenue This Year
- M N/A
- PRCT $47.40
- Revenue Next Year
- M N/A
- PRCT $31.55
- P/E Ratio
- M $5.57
- PRCT N/A
- Revenue Growth
- M N/A
- PRCT 59.36
- 52 Week Low
- M $9.76
- PRCT $47.04
- 52 Week High
- M $20.47
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- M 40.90
- PRCT 52.43
- Support Level
- M $11.19
- PRCT $58.34
- Resistance Level
- M $11.89
- PRCT $61.43
- Average True Range (ATR)
- M 0.42
- PRCT 2.61
- MACD
- M -0.10
- PRCT -0.37
- Stochastic Oscillator
- M 3.68
- PRCT 38.21
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's nameplate, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's nameplates, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.